Drugs / Bone marrow-derived stem cells
Trials 2 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/21 trial | ||||||
| Phase 1/2 | NCT03078621 | Sep 2016 → Oct 2020 | cerebral palsy | Stem Cells Arabia | Unknown | No outcome recorded |
| Phase not applicable1 trial | ||||||
| — | NCT02240342 | Sep 2014 → Mar 2015 | ovarian dysfunction | Hospital Universitario La Fe | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | bone marrow-derived stem cells | “purified autologous bone marrow-derived stem cells and mesenchymal stem cells” NCT03078621 ↗1“INTERVENTION(S): Ovarian infusion of bone marrow-derived stem cells.” PMID 29960701 ↗ Jun 2018 |
| Modality | Cell therapy | “bone marrow-derived stem cells” NCT03078621 ↗ |
| Route | Other | “infused into the ovarian artery” NCT02240342 ↗ |